Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 21Anus Neoplasms 17Carcinoma, Hepatocellular 11Appendiceal Neoplasms 11Stomach Neoplasms 10Neoplasm Metastasis 9Peritoneal Neoplasms 8Pancreatic Neoplasms 8Colonic Neoplasms 6Rectal Neoplasms 5Liver Neoplasms 5Anal Canal Carcinoma 4Ovarian Neoplasms 3Gastrointestinal Neoplasms 3Uterine Neoplasms 2Pseudomyxoma Peritonei 2Uterine Cervical Neoplasms 1Sarcoma 1Recurrence Hepatocellular Carcinoma 1Recurrence 1Pleural Neoplasms 1Peritoneal Diseases 1Neoplasms, Squamous Cell 1Neoplasms 1Necrosis 1Mesothelioma 1Mediastinal Neoplasms 1Locally Advanced Anal Canal Cancer 1Hyperthermia 1HIV Infections 1

Interventions

Mitomycin 1Ethiodized Oil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence Hepatocellular Carcinoma × Mitomycin × Gastrointestinal × Clear all
NCT02638857 2016-01-01

Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma

Second Military Medical University

Phase 1/2 Unknown
60 enrolled
Gastrointestinal

Recurrence Hepatocellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡